儿童骨肉瘤FDG PET代谢与体积参数的预后价值:一项假设生成研究
该前瞻性研究纳入34例骨肉瘤患者,在新辅助化疗前、中、后行FDG PET/CT,测量SUVmax、SUVpeak、MTV和TLG,评估其对无事件生存和总生存的预测价值;基线及 Interim/治疗后参数可预测生存,基线MTV为独立预测因子。
要点
- 基线SUVpeak、MTV、TLG可预测EFS和OS,但与组织学反应无关。
- 化疗中期及治疗后SUVmax、SUVpeak、MTV、TLG与组织学反应相关。
- 基线MTV是EFS和OS的独立预测因子(HR分别为5.0和29.4)。
核心结论
- 基线、化疗中期或治疗后的SUVpeak、MTV和TLG可预测骨肉瘤患者的无事件生存和总生存,可能是有用的预后生物标志物。
研究设计与样本
- 前瞻性研究,2008至2012年纳入34例骨肉瘤患者,在新辅助化疗前(基线)、化疗中(中期)和化疗后(治疗后)行FDG PET/CT,参考标准为组织学反应及生存结局。
诊断标准与关键数值
- 基线SUVpeak、MTV和TLG预测EFS(P=0.006-0.03)和OS(P=0.001-0.03)。
- 中期及治疗后SUVmax、SUVpeak、MTV和TLG与组织学反应相关(P=0.0002-0.04)。
- 基线MTV预测EFS的HR为5.0(95%CI:1.5,16.8),预测OS的HR为29.4(95%CI:2.2,392.2)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To preliminarily assess the potential prognostic value of various fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) parameters before, during, and after neoadjuvant chemotherapy (NCT). Materials and Methods Thirty-four patients with osteosarcoma were enrolled prospectively from 2008 to 2012 and underwent FDG PET/computed tomography (CT) imaging before (baseline scan), during (interim scan) and after NCT (posttherapy scan). The study was approved by the institutional review board and informed consent was received from patients. Maximum and peak standardized uptake value (SUVmax and SUVpeak), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were measured. Predictive value of FDG PET parameters for event-free survival (EFS) and overall survival (OS) were evaluated. Multivariable Cox regression analysis for EFS and OS was performed by using histologic response and initial presence of metastasis as covariates. Results At baseline scan, SUVpeak, MTV, and TLG were predictive of EFS (P = .006-.03) and OS (P = .001-.03) but not associated with histologic response. At interim and posttherapy scan, SUVmax, SUVpeak, MTV, and TLG were associated with histologic response (P = .0002-.04) and predictive of EFS (P = .004-.02) and OS (P = .001-.03). Multivariable Cox regression analysis revealed that the FDG PET parameters either at baseline, interim, or posttherapy were independently predictive of EFS and OS. In particular, baseline MTV was an independent predictor of EFS (hazard ratio, 5.0 [95% confidence interval {CI}: 1.5, 16.8]) and OS (hazard ratio, 29.4 [95% CI: 2.2, 392.2]). Conclusion SUVpeak, MTV, and TLG either at baseline, interim, or posttherapy were predictive of EFS and OS and may be useful prognostic biomarkers for osteosarcoma. © RSNA, 2018 Online supplemental material is available for this article.
引用
- Im HJ, Zhang Y, Wu H, et al. Prognostic Value of Metabolic and Volumetric Parameters of FDG PET in Pediatric Osteosarcoma: A Hypothesis-generating Study. Radiology. 2018. PMID: 29357275. doi:10.1148/radiol.2017162758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。